Advanced search
1 file | 315.82 KB Add to list

The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier

Lieselotte Moerman (UGent) , Caroline Dumolyn (UGent) , Paul Boon (UGent) and Filip De Vos (UGent)
(2012) NUCLEAR MEDICINE AND BIOLOGY. 39(1). p.121-125
Author
Organization
Keywords
P-glycoprotein, 11C-laniquidar, 11C-desmethylloperamide, PET tracers, Multidrug resistance, Mdrla (-/-) mice, In vivo experiments, P-gp inhibitors, P-gp substrates, MULTIDRUG-RESISTANCE, TRANSPORTERS, INHIBITORS, EFFLUX, DRUGS, RADIOSYNTHESIS, RADIOLIGAND, MICE, PET

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 315.82 KB

Citation

Please use this url to cite or link to this publication:

MLA
Moerman, Lieselotte, et al. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY, vol. 39, no. 1, 2012, pp. 121–25, doi:10.1016/j.nucmedbio.2011.06.009.
APA
Moerman, L., Dumolyn, C., Boon, P., & De Vos, F. (2012). The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier. NUCLEAR MEDICINE AND BIOLOGY, 39(1), 121–125. https://doi.org/10.1016/j.nucmedbio.2011.06.009
Chicago author-date
Moerman, Lieselotte, Caroline Dumolyn, Paul Boon, and Filip De Vos. 2012. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY 39 (1): 121–25. https://doi.org/10.1016/j.nucmedbio.2011.06.009.
Chicago author-date (all authors)
Moerman, Lieselotte, Caroline Dumolyn, Paul Boon, and Filip De Vos. 2012. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY 39 (1): 121–125. doi:10.1016/j.nucmedbio.2011.06.009.
Vancouver
1.
Moerman L, Dumolyn C, Boon P, De Vos F. The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier. NUCLEAR MEDICINE AND BIOLOGY. 2012;39(1):121–5.
IEEE
[1]
L. Moerman, C. Dumolyn, P. Boon, and F. De Vos, “The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier,” NUCLEAR MEDICINE AND BIOLOGY, vol. 39, no. 1, pp. 121–125, 2012.
@article{1981276,
  author       = {{Moerman, Lieselotte and Dumolyn, Caroline and Boon, Paul and De Vos, Filip}},
  issn         = {{0969-8051}},
  journal      = {{NUCLEAR MEDICINE AND BIOLOGY}},
  keywords     = {{P-glycoprotein,11C-laniquidar,11C-desmethylloperamide,PET tracers,Multidrug resistance,Mdrla (-/-) mice,In vivo experiments,P-gp inhibitors,P-gp substrates,MULTIDRUG-RESISTANCE,TRANSPORTERS,INHIBITORS,EFFLUX,DRUGS,RADIOSYNTHESIS,RADIOLIGAND,MICE,PET}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{121--125}},
  title        = {{The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier}},
  url          = {{http://doi.org/10.1016/j.nucmedbio.2011.06.009}},
  volume       = {{39}},
  year         = {{2012}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: